We are live on ! Find out more
HAE icon

Haemonetics

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 328324 (-4)

6.15% less ownership

Funds ownership: 108.62%102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
76
Legal & General Group
United Kingdom
$3.68M -$697K -10,696 -14%
IP
77
Isthmus Partners
Wisconsin
$3.68M -$155K -2,381 -4%
Retirement Systems of Alabama
78
Retirement Systems of Alabama
Alabama
$3.21M +$51.5K +791 +1%
Point72 Asset Management
79
Point72 Asset Management
Connecticut
$3.21M -$51.9M -796,511 -93%
EGM
80
Engineers Gate Manager
New York
$3.2M +$2.18M +33,456 +144%
New York State Teachers Retirement System (NYSTRS)
81
New York State Teachers Retirement System (NYSTRS)
New York
$3.11M -$50.2K -771 -1%
RHJA
82
Rice Hall James & Associates
California
$3.05M -$54.7K -840 -2%
California State Teachers Retirement System (CalSTRS)
83
California State Teachers Retirement System (CalSTRS)
California
$2.96M +$451K +6,931 +15%
YIH
84
Y-Intercept (HK)
Hong Kong
$2.89M +$1.86M +28,586 +126%
AAI
85
Aequim Alternative Investments
California
$2.89M +$3.33M +51,200 New
Fifth Third Bancorp
86
Fifth Third Bancorp
Ohio
$2.86M +$3.28M +50,400 +12,475%
State of Wisconsin Investment Board
87
State of Wisconsin Investment Board
Wisconsin
$2.76M -$208K -3,198 -6%
GAM
88
Gotham Asset Management
New York
$2.75M +$1.96M +30,028 +160%
BA
89
Bridgewater Associates
Connecticut
$2.73M +$3.15M +48,377 New
MIM
90
MetLife Investment Management
New Jersey
$2.71M -$72.7K -1,117 -2%
ECM
91
ExodusPoint Capital Management
New York
$2.69M -$3.16M -48,568 -50%
RP
92
Riverwater Partners
Wisconsin
$2.6M +$980K +15,041 +49%
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$2.48M -$1.56M -23,975 -35%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.44M -$187K -2,877 -6%
Renaissance Technologies
95
Renaissance Technologies
New York
$2.43M +$2.81M +43,200 New
VAM
96
Vanguard Asset Management
$2.38M +$2.75M +42,290 New
Wells Fargo
97
Wells Fargo
California
$2.38M -$3.18M -48,839 -54%
PCM
98
Peregrine Capital Management
Minnesota
$2.38M +$883K +13,553 +47%
Federated Hermes
99
Federated Hermes
Pennsylvania
$2.26M +$75.2K +1,154 +3%
Cerity Partners
100
Cerity Partners
New York
$2.25M +$325K +4,991 +14%

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.